← Back to patent-cliff list
Perflutren
Tier C — Watch / tradePerflutren
-
Originator
1998
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Brand：Aerosomes, Optison, Luminity, Definity
Indications (approved)：Contrast imaging, Cardiovascular contrast agent
Regional status
US
Approved
2001-07-31
EU
Approved
1998-05-17
China
No progress
2017-08-11
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Perflutren?
Approved indications include: Contrast imaging, Cardiovascular contrast agent.
When does the Perflutren patent expire?
No public expiry year is available for Perflutren yet; this page updates once verified.
How do I get a quote for Perflutren intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27